Net Cash Provided by (Used in) Financing Activities in USD of INTEGRA LIFESCIENCES HOLDINGS CORP from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Integra Lifesciences Holdings Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2025.
  • Integra Lifesciences Holdings Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $35.4M, a 90.1% decline year-over-year.
  • Integra Lifesciences Holdings Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $238M.
  • Integra Lifesciences Holdings Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$230M, a 8.74% increase from 2022.
  • Integra Lifesciences Holdings Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$252M, a 157% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

INTEGRA LIFESCIENCES HOLDINGS CORP Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $35.4M -$323M -90.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-05
Q1 2024 $359M +$521M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05
Q1 2023 -$163M -$29.2M -21.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q1 2022 -$133M -$130M -4327% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q1 2021 -$3.02M -$165M -102% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q1 2020 $162M +$157M +2904% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q1 2019 $5.39M +$26.3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 -$20.9M -$206M -111% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q1 2017 $185M +$175M +1759% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-26
Q1 2016 $9.95M +$23.8M Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q1 2015 -$13.8M -$257M -106% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-27
Q1 2014 $243M +$243M +94520% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q1 2013 $257K +$12.8M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q1 2012 -$12.6M +$31.9M +71.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q1 2011 -$44.5M -$35M -370% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q1 2010 -$9.46M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28

INTEGRA LIFESCIENCES HOLDINGS CORP Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $238M +$468M Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 -$230M +$22M +8.74% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 -$252M -$154M -157% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 -$98.2M -$220M -181% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $122M +$130M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 -$8.77M +$172M +95.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$181M -$1.35B -115% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $1.17B +$1.18B Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 -$15.1M -$263M -106% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $248M +$9.46M +3.96% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $239M +$220M +1155% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 $19M +$7.27M +61.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 $11.8M -$48.4M -80.5% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 $60.1M +$61.7M Jan 1, 2011 Dec 31, 2011 8-K 2014-06-20
2010 -$1.57M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.